Aspiriant LLC Portfolio holdings
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$20M |
| 2 |
Vanguard Small-Cap Value ETF
VBR
|
+$19.6M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$14.3M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$9.05M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$8.72M |
Top Sells
| 1 |
iShares National Muni Bond ETF
MUB
|
+$3.77M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$3.17M |
| 3 |
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
|
+$2.99M |
| 4 |
Apple
AAPL
|
+$2.6M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$2.24M |
Sector Composition
| 1 | Technology | 4.12% |
| 2 | Financials | 2.19% |
| 3 | Communication Services | 1.35% |
| 4 | Healthcare | 0.61% |
| 5 | Consumer Discretionary | 0.57% |
Similar funds
Aspiriant LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Aspiriant LLC held 329 positions worth $3.48B, up 6.4% from $3.27B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Aspiriant LLC deployed $149M of net new capital in Q4 2025, opening 32 new positions and adding to 177 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.
By sector, the portfolio is most concentrated in Technology at 4.1% of assets, up from 4% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $3.77M trimmed.
- Aspiriant LLC's largest Q4 2025 buy was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.
- Aspiriant LLC added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $20M increase.
- Aspiriant LLC's biggest Q4 2025 reduction was iShares National Muni Bond ETF, cutting an estimated $3.77M.
- Aspiriant LLC fully exited Vanguard Total International Bond ETF in Q4 2025, selling an estimated $906K.
- Aspiriant LLC's ten largest holdings make up 63% of its $3.48B portfolio in Q4 2025.
- Aspiriant LLC opened 32 new positions and closed 10 in Q4 2025.
- Aspiriant LLC's portfolio value rose 6.4% quarter-over-quarter to $3.48B.
Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.